Probiotic Lactobacilli: A New Perspective for the Treatment of Inflammatory Bowel Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|24|1973-1980

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.24, 2003-09, pp. : 1973-1980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New developments in the treatment of inflammatory bowel disease

By Keshavarzian Ali   Farhadi Ashkan   Mutlu Ece A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 365-385

Informa Healthcare

Access to resources Recommend Favorite

Budesonide: Teaching an Old Dog New Tricks for Inflammatory Bowel Disease Treatment

By  

Current Medicinal Chemistry, Vol. 15, Iss. 24, 2008-10 ,pp. : 2527-2535

Bentham Science Publishers

Access to resources Recommend Favorite

Mesalazine for the treatment of inflammatory bowel disease

By Criscuoli Valeria  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite

Thiopurine Treatment in Inflammatory Bowel Disease

By Gardiner Sharon J.  

Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. : 803-804

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

By Schwab M.   Klotz U.  

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 723-751

Adis International

Access to resources Recommend Favorite